15857-70-2 Usage
Description
(3,4-dihydro-2H-1-benzothiopyran-4-yl)ammonium chloride, also known as DBT, is a benzothiopyran derivative that exists as an ammonium salt with the chloride ion as the counterion. It is a versatile chemical compound with potential applications in various fields.
Uses
Used in Organic and Medicinal Chemistry:
DBT is used as a building block for the synthesis of various pharmaceuticals and other organic compounds due to its unique chemical structure and properties.
Used in Antifungal and Antimicrobial Applications:
DBT is known for its potential biological activities, including antifungal and antimicrobial properties, making it a valuable compound for developing new treatments and products in these areas.
Used in Neurological Disorder Treatment:
Research has shown that DBT may have potential applications in the treatment of neurological disorders, indicating its potential as a therapeutic agent in the medical field.
Check Digit Verification of cas no
The CAS Registry Mumber 15857-70-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,8,5 and 7 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 15857-70:
(7*1)+(6*5)+(5*8)+(4*5)+(3*7)+(2*7)+(1*0)=132
132 % 10 = 2
So 15857-70-2 is a valid CAS Registry Number.
InChI:InChI:1S/C9H11NS.ClH/c10-8-5-6-11-9-4-2-1-3-7(8)9;/h1-4,8H,5-6,10H2;1H
15857-70-2Relevant articles and documents
IMINOPYRIDINE DERIVATIVE AND USE THEREOF
-
Page/Page column 46-47, (2011/01/12)
The present invention aims to provide a compound having a superior selective α1D adrenergic receptor antagonistic action and useful as an agent for the prophylaxis or treatment of a lower urinary tract disease and the like.The present invention provides a compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof.The present invention aims to provide a compound having a superior selective ± 1D adrenergic receptor antagonistic action and useful as an agent for the prophylaxis or treatment of a lower urinary tract disease and the like. The present invention provides a compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof.